Substance / Medication

Phenoxybenzamine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Functional and safety outcomes after benign prostatic enlargement surgeries in men with detrusor underactivity compared with normal detrusor contractility: Systematic review and meta-analysis.
Wroclawski Marcelo Langer, Takemura Lucas Seiti, Santos Hugo Octaviano Duarte et al. · Neurourol Urodyn · 2024
PMID: 38010924Meta-Analysis
Efficacy of transurethral botulinum toxin A injections for bladder outlet obstruction: A systematic review and meta-analysis.
Gavi Filippo, Ragonese Mauro, Fettucciari Daniele et al. · Urologia · 2024
PMID: 38372240Meta-Analysis
The bladder contractility and bladder outlet obstruction indices in adult men: Results of a global Delphi consensus study.
Sinha Sanjay, Finazzi-Agrò Enrico, Dmochowski Roger Roman et al. · Neurourol Urodyn · 2023
PMID: 36273413Meta-Analysis
Effect of bladder outlet procedures on urodynamic assessments in men with an acontractile or underactive detrusor: A systematic review and meta-analysis.
van Merode Nadine A M, Nijholt Ingrid M, Heesakkers John P et al. · Neurourol Urodyn · 2023
PMID: 37498009Meta-Analysis
Clarification of the USP compendial procedure for phenoxybenzamine hydrochloride via updating impurity profiles.
Xu Qun, Min Donald, Petr Rachael et al. · J Pharm Biomed Anal · 2020
PMID: 32942108Other
Anti-tumor activity of phenoxybenzamine hydrochloride on malignant glioma cells.
Lin Xian-Bin, Jiang Lei, Ding Mao-Hua et al. · Tumour Biol · 2016
PMID: 26409450Preclinical
Phenoxybenzamine hydrochloride.
[object Object] · Rep Carcinog · 2011
PMID: 21863081Preclinical
Phenoxybenzamine hydrochloride.
Rep Carcinog · 2004
PMID: 21089945Preclinical
Phenoxybenzamine hydrochloride.
[object Object] · Rep Carcinog · 2002
PMID: 15332291Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Phenoxybenzamine hydrochloride (substance)
SNOMED CT
44293009
UMLS CUI
C0242430

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.